As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles Current group exhibitions In their last group exhibition, Knudsen’s works were ...

Kendisfrisøren har været uden kørekort siden 2023, men i år må han igen erhverve sig et nyt kort, hvilket er planen Dennis Knudsen er netop landet i Danmark ... Han fik desuden beslaglagt sin Audi Q7 ...

The company is investing Rs 850 crore primarily into manufacturing plants. Lauritz Knudsen, part of Schneider Electric Group, is exploring innovations such as hydrogen analysers and wind energy ...

With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet ...

I will be particularly interested in the company’s plan to attract and retain weight loss subscribers in the coming absence of popular GLP-1 compounds.